Literature DB >> 19470039

Increased expression of CRTH2 on eosinophils in allergic skin diseases.

H Yahara, T Satoh, C Miyagishi, H Yokozeki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470039     DOI: 10.1111/j.1468-3083.2009.03267.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  13 in total

1.  Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.

Authors:  Yoshihiro Yamamoto; Shinobu Otani; Hiroyuki Hirai; Kinya Nagata; Kosuke Aritake; Yoshihiro Urade; Shuh Narumiya; Hiroo Yokozeki; Masataka Nakamura; Takahiro Satoh
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

2.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils.

Authors:  Tsukasa Ugajin; Takahiro Satoh; Toru Kanamori; Kosuke Aritake; Yoshihiro Urade; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

4.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

5.  The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge.

Authors:  Rui He; Michiko K Oyoshi; James Y T Wang; Martin R Hodge; Haoli Jin; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2010-08-14       Impact factor: 10.793

6.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 7.  Current and emerging treatments for chronic spontaneous urticaria.

Authors:  Kirti J Johal; Sarbjit S Saini
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-05       Impact factor: 6.347

Review 8.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

9.  New and Emerging Therapies for Pediatric Atopic Dermatitis.

Authors:  Henry L Nguyen; Katelyn R Anderson; Megha M Tollefson
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

Review 10.  Looking forward to new targeted treatments for chronic spontaneous urticaria.

Authors:  Emek Kocatürk; Marcus Maurer; Martin Metz; Clive Grattan
Journal:  Clin Transl Allergy       Date:  2017-01-10       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.